3 Year Absolute Returns
76.77% ↑
NAV (₹) on 16 Nov 2026
52.27
1 Day NAV Change
-0.62%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment ... Read more
AUM
₹ 3,727.17 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 66.91% |
| Hospitals & Medical Services | 19.05% |
| Foreign Securities | 8.61% |
| Treps/Reverse Repo | 2.22% |
| Medical Equipment & Accessories | 1.25% |
| International Mutual Fund Units | 1.09% |
| Finance - Non Life Insurance | 1.02% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Apollo Hospitals Enterprise Limited | 7.89% | ₹ 293.96 | Hospitals & Medical Services |
| IPCA Laboratories Limited | 7.49% | ₹ 279.12 | Pharmaceuticals |
| Cipla Limited | 7.40% | ₹ 275.97 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 7.32% | ₹ 272.98 | Pharmaceuticals |
| Gland Pharma Limited | 6.61% | ₹ 246.21 | Pharmaceuticals |
| Sai Life Sciences Limited | 6.17% | ₹ 229.79 | Pharmaceuticals |
| Globus Medical Inc | 5.36% | ₹ 199.83 | Others |
| Alkem Laboratories Limited | 4.73% | ₹ 176.24 | Pharmaceuticals |
| Divi's Laboratories Limited | 4.41% | ₹ 164.52 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.82% | ₹ 142.31 | Pharmaceuticals |
| Alembic Pharmaceuticals Limited | 3.09% | ₹ 115.09 | Pharmaceuticals |
| Thyrocare Technologies Limited | 2.84% | ₹ 105.83 | Hospitals & Medical Services |
| Kovai Medical Center And Hospital Limited | 2.76% | ₹ 103.03 | Hospitals & Medical Services |
| Pfizer Limited | 2.61% | ₹ 97.22 | Pharmaceuticals |
| Concord Biotech Limited | 2.46% | ₹ 91.65 | Pharmaceuticals |
| Procter & Gamble Health Limited | 2.42% | ₹ 90.32 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.39% | ₹ 89.01 | Hospitals & Medical Services |
| TREPS / Reverse Repo Investments | 2.22% | ₹ 82.61 | Others |
| Intuitive Surgical Inc | 2.07% | ₹ 77.23 | Others |
| Indoco Remedies Limited | 1.81% | ₹ 67.61 | Pharmaceuticals |
| Syngene International Limited | 1.76% | ₹ 65.61 | Pharmaceuticals |
| Manipal Health Enterprises Limited | 1.76% | ₹ 65.58 | Hospitals & Medical Services |
| Unichem Laboratories Limited | 1.47% | ₹ 54.67 | Pharmaceuticals |
| Eris Lifesciences Limited | 1.20% | ₹ 44.73 | Pharmaceuticals |
| Abbott India Limited | 1.14% | ₹ 42.42 | Pharmaceuticals |
| Sahajanand Medical Technologies Limited | 1.12% | ₹ 41.76 | Medical Equipment & Accessories |
| Global X Funds - Global X Genomics & Biotechnology ETF | 1.09% | ₹ 40.61 | Others |
| Nephrocare Health Services Limited | 1.05% | ₹ 39.02 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Co Limited | 1.02% | ₹ 38.16 | Finance - Non Life Insurance |
| Aarti Drugs Limited | 1.00% | ₹ 37.09 | Pharmaceuticals |
| Abbott Laboratories | 0.86% | ₹ 31.96 | Others |
| Jupiter Life Line Hospitals Limited | 0.36% | ₹ 13.60 | Hospitals & Medical Services |
| Grail Inc | 0.32% | ₹ 11.93 | Others |
| Laxmi Dental Limited | 0.13% | ₹ 4.98 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 26.93% | 18.30% | 8.82% | 20.91% |
| Category returns | 7.37% | 5.10% | 9.83% | 22.69% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
What is the current NAV of DSP Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of DSP Healthcare Fund - Direct Plan Growth?
What are the historical returns of DSP Healthcare Fund - Direct Plan Growth?
What is the risk level of DSP Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for DSP Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article